Advice panel gives conditional OK to controversial puberty blockers
Puberty blockers should remain a clinical option for certain children with gender dysphoria despite limited evidence about their benefits and harms, according to long-awaited national advice.
We haven't written up this one. ABC News AU has the full story — the link below goes straight to it.